These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9080145)

  • 41. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging.
    Ohno Y; Hatabu H; Takenaka D; Higashino T; Watanabe H; Ohbayashi C; Yoshimura M; Satouchi M; Nishimura Y; Sugimura K
    Radiology; 2004 Jun; 231(3):872-9. PubMed ID: 15163823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN; Francis IR
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection and size of pulmonary lesions: how accurate is MRI? A prospective comparison of CT and MRI.
    Heye T; Ley S; Heussel CP; Dienemann H; Kauczor HU; Hosch W; Libicher M
    Acta Radiol; 2012 Mar; 53(2):153-60. PubMed ID: 22287146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system.
    Oudkerk M; Sijens PE; Van Beek EJ; Kuijpers TJ
    Invest Radiol; 1995 Feb; 30(2):75-8. PubMed ID: 7782190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group.
    Webb WR; Gatsonis C; Zerhouni EA; Heelan RT; Glazer GM; Francis IR; McNeil BJ
    Radiology; 1991 Mar; 178(3):705-13. PubMed ID: 1847239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
    Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
    Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diagnostic value of enhanced computed tomography plus vascular endothelial growth factor C expression in hilar and mediastinal lymph node metastasis of non-small cell lung cancer].
    Li SL; Zheng QF; Chen JF; Wu N; Yan S; Wang YZ; Lü C; Zhang LJ; Yang Y
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(37):2624-7. PubMed ID: 23290064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma.
    Gdeedo A; Van Schil P; Corthouts B; Van Mieghem F; Van Meerbeeck J; Van Marck E
    Eur J Cardiothorac Surg; 1997 Aug; 12(2):224-7. PubMed ID: 9288511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
    Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
    Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Staging of bronchogenic cancer. Determination of mediastinal lymphatic involvement using magnetic resonance].
    Crisci R; Pavone P; Giuliani S; Di Egidio M; Vecchio L; Passariello R; Coloni GF
    Minerva Chir; 1990 Feb; 45(3-4):147-52. PubMed ID: 2356028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
    Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
    Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Staging of urinary bladder neoplasms with MR imaging: is Gd-DTPA helpful?
    Neuerburg JM; Bohndorf K; Sohn M; Teufl F; Günther RW
    J Comput Assist Tomogr; 1991; 15(5):780-6. PubMed ID: 1885795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation].
    Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R
    Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study].
    Vogl TJ; Friebe CE; Balzer T; Mack MG; Steiner S; Schedel H; Pegios W; Lanksch W; Banzer D; Felix R
    Radiologe; 1995 Aug; 35(8):508-16. PubMed ID: 7568795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical studies for usefulness of Gd-DTPA enhanced MRI in lung cancer].
    Kusumoto M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Mar; 52(3):358-71. PubMed ID: 1315952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
    De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
    J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer].
    Yang WF; Tan GZ; Fu Z; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):925-8. PubMed ID: 20193335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mediastinal nodes in patients with non-small cell lung cancer: MRI findings with PET/CT and pathologic correlation.
    Yeh DW; Lee KS; Han J; Yi CA; Lee HY; Chung MJ; Kim TS
    AJR Am J Roentgenol; 2009 Sep; 193(3):813-21. PubMed ID: 19696297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interobserver variability in CT and MR staging of lung cancer.
    Webb WR; Sarin M; Zerhouni EA; Heelan RT; Glazer GM; Gatsonis C
    J Comput Assist Tomogr; 1993; 17(6):841-6. PubMed ID: 8227566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.